Shaping the Future of Imaging: Biolight Biotechnology Shines at Analytica 2026 in Munich, Showcasing the Strength of Chinese Innovation

On March 24–27, local time, Analytica 2026 – the Munich International Trade Fair for Laboratory Technology, Analysis, and Biotechnology – the world's leading international trade fair in the field of analytical sciences, was grandly held at the Messe München Exhibition Center in Munich, Germany.

Biolight Biotechnology, Chinese high-end manufacturer of life science instruments, presented two core product lines—intelligent molecular imaging systems and multimodal in vivo imaging platforms. Through comprehensive technological innovation and intelligent solutions, Biolight Biotechnology once again demonstrated the R&D strength and innovation capacity of Chinese high-end scientific instruments, becoming one of the most prominent representatives of Chinese innovation at the exhibition.

Continuous Innovation: Advancing High-Precision and Intelligent Imaging Solutions

Following its successful debut at Analytica 2024, which gained significant global attention, Biolight Biotechnology has continued to strengthen its core technological capabilities.

At Analytica 2026, the company introduced major upgrades across both product lines, achieving breakthroughs in performance and user experience. These innovations are closely aligned with the global demand for high-precision, intelligent, and multi-scenario imaging solutions in life science research, becoming a key highlight of the exhibition.

The molecular imaging product line integrates electrophoresis, blotting, and imaging systems into a unified workflow solution. The newly upgraded multimodal electrophoresis workstation features multiple electrophoresis functions and an innovative intelligent interactive system, delivering both high performance and ease of use.

The in vivo imaging product line enables comprehensive imaging of both plant and animal models. By integrating multimodal imaging technologies, it achieves precise fusion of functional and structural imaging, providing robust support for advanced research across multiple scientific fields. The innovation and performance of both product lines attracted significant attention throughout the exhibition.

Strong Global Engagement and Market Recognition

During the exhibition, the Biolight Biotechnology booth maintained high levels of visitor engagement. Distributors, biotechnology companies, and end-users from different countries and regions visited the booth for technical discussions and hands-on demonstrations of the company’s core technologies.

After practical evaluation, many attendees highly praised the systems for their intelligent design, high-precision imaging performance, and broad application versatility. Several European distributors expressed strong interest in establishing long-term cooperation and distribution partnerships on site, highlighting the global competitiveness of Biolight Biotechnology's solutions.

From Product Breakthrough to Global Expansion: Advancing Chinese Innovation on the World Stage

From its remarkable debut in 2024 to its upgraded presence in 2026 with two major innovative product lines, Biolight Biotechnology demonstrate a steady evolution from “Made in China” to “Intelligent Manufacturing in China.”

As a representative of China's high-end life science instrumentation sector, Biolight Biotechnology remains committed to advancing global life science research through continuous technological innovation. By breaking technological barriers in high-end imaging systems, the company is accelerating the global adoption of Chinese-developed scientific instruments and strengthening its presence in international markets.

Looking ahead, Biolight Biotechnology will continue to drive innovation, expand its global collaborations, and contribute to the advancement of life sciences worldwide through intelligent imaging technologies and integrated solutions.